Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,099

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

Böhm, Michael, Swedberg, Karl, Komajda, Michel, Borer, Jeffrey S, Ford, Ian, Dubost-Brama, Ariane, Lerebours, Guy, Tavazzi, Luigi·2010·The Lancet
DOI 10.1016/s0140-6736(10)61259-7
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(10)61259-7

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 30

  1. Kannel, 1987, Heart rate and cardiovascular mortality: the Framingham Study, Am Heart J, 113, 1489, 10.1016/0002-8703(87)90666-1 · DOI · Paper page
  2. Kolloch, 2008, Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST), Eur Heart J, 29, 1327, 10.1093/eurheartj/ehn123 · DOI · Paper page
  3. Lechat, 2001, Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial, Circulation, 103, 1428, 10.1161/01.CIR.103.10.1428 · DOI · Paper page
  4. Pocock, 2006, Predictors of mortality and morbidity in patients with chronic heart failure, Eur Heart J, 27, 65, 10.1093/eurheartj/ehi555 · DOI · Paper page
  5. Custodis, 2008, Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice, Circulation, 117, 2377, 10.1161/CIRCULATIONAHA.107.746537 · DOI · Paper page
  6. Beere, 1984, Retarding effect of lowered heart rate on coronary atherosclerosis, Science, 226, 180, 10.1126/science.6484569 · DOI · Paper page
  7. Perski, 1988, Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients, Am Heart J, 116, 1369, 10.1016/0002-8703(88)90469-3 · DOI
  8. Reil, 2008, BEAUTIFUL results—the slower, the better?, Lancet, 372, 779, 10.1016/S0140-6736(08)61172-1 · DOI
  9. Hasenfuss, 1994, Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium, Circ Res, 75, 434, 10.1161/01.RES.75.3.434 · DOI · Paper page
  10. Mulieri, 1992, Altered myocardial force-frequency relation in human heart failure, Circulation, 85, 1743, 10.1161/01.CIR.85.5.1743 · DOI · Paper page
  11. Conway, 1991, Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy, Lancet, 338, 973, 10.1016/0140-6736(91)91838-L · DOI · Paper page
  12. Mulder, 2004, Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, 109, 1674, 10.1161/01.CIR.0000118464.48959.1C · DOI · Paper page
  13. Colin, 2004, Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs, J Pharmacol Exp Ther, 308, 236, 10.1124/jpet.103.059717 · DOI
  14. Swedberg, 2010, Effects of ivabradine on outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study, Lancet
  15. DiFrancesco, 2004, Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease, Drugs, 64, 1757, 10.2165/00003495-200464160-00003 · DOI · Paper page
  16. Swedberg, 2010, Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT), Eur J Heart Fail, 12, 75, 10.1093/eurjhf/hfp154 · DOI
  17. Pocock, 2006, Predictors of mortality and morbidity in patients with chronic heart failure, Eur Heart J, 27, 65, 10.1093/eurheartj/ehi555 · DOI · Paper page
  18. Bucchi, 2002, Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine, J Gen Physiol, 120, 1, 10.1085/jgp.20028593 · DOI · Paper page
  19. Hasenfuss, 1994, Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy, Eur Heart J, 15, 164, 10.1093/oxfordjournals.eurheartj.a060471 · DOI
  20. Kelly, 1992, Effective arterial elastance as index of arterial vascular load in humans, Circulation, 86, 513, 10.1161/01.CIR.86.2.513 · DOI · Paper page
  21. Reil, 2009, Heart rate reduction by If-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction, Trends Cardiovasc Med, 19, 152, 10.1016/j.tcm.2009.09.002 · DOI
  22. Kurita, 2007, Impact of heart rate on mechanical dyssynchrony and left ventricular contractility in patients with heart failure and normal QRS duration, Eur J Heart Fail, 9, 637, 10.1016/j.ejheart.2007.03.002 · doi:10.1016/j.ejheart.2007.03.002
  23. Kindermann, 2002, Defining the optimum upper heart rate limit during exercise: a study in pacemaker patients with heart failure, Eur Heart J, 23, 1301, 10.1053/euhj.2001.3078 · DOI
  24. Logeart, 2009, Heart rate per se impacts cardiac function in patients with systolic heart failure and pacing: a pilot study, Eur J Heart Fail, 11, 53, 10.1093/eurjhf/hfn016 · DOI
  25. Flannery, 2008, Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers, Am J Cardiol, 101, 865, 10.1016/j.amjcard.2007.11.023 · DOI
  26. Gullestad, 2005, What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF), J Am Coll Cardiol, 45, 252, 10.1016/j.jacc.2004.10.032 · DOI
  27. Metra, 2005, Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial, Eur Heart J, 26, 2259, 10.1093/eurheartj/ehi386 · DOI · Paper page
  28. McAlister, 2009, Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure, Ann Intern Med, 150, 784, 10.7326/0003-4819-150-11-200906020-00006 · DOI · Paper page
  29. Communal, 1998, Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway, Circulation, 98, 1329, 10.1161/01.CIR.98.13.1329 · DOI · Paper page
  30. Lohse, 1996, Mechanisms of beta-adrenergic receptor desensitization: from molecular biology to heart failure, Basic Res Cardiol, 91, 29, 10.1007/BF00795359 · doi:10.1007/bf00795359

Cited by

See all 1,099

Metadata

Authors
Böhm, M., Swedberg, K., Komajda, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L.
Venue
The Lancet
Publisher
Elsevier BV
Published
2010-09
Volume
376
Issue
9744
Pages
886-894
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(10)61259-7
OpenAlex
W2154143064
Cited by
1,099
References
4
FWCI
54.16
Type
journal article
Language
en
Open access
closed
Licence
Funders
  • Boehringer Ingelheim
  • AstraZeneca
  • Novartis
  • Amgen
  • Pfizer
  • Sanofi

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(10)61259-7
The paper
Böhm, M., Swedberg, K., Komajda, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010). Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(10)61259-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.